{"id":"https://openalex.org/W2005259934","doi":"https://doi.org/10.1001/archneur.60.6.843","title":"Analysis of Outcome in Retrieved Dropout Patients in a Rivastigmine vs Placebo, 26-Week, Alzheimer Disease Trial","display_name":"Analysis of Outcome in Retrieved Dropout Patients in a Rivastigmine vs Placebo, 26-Week, Alzheimer Disease Trial","alternate_titles":[],"publication_year":2003,"publication_date":"2003-06-01","ids":{"openalex":"https://openalex.org/W2005259934","doi":"https://doi.org/10.1001/archneur.60.6.843","mag":"2005259934","pmid":"https://pubmed.ncbi.nlm.nih.gov/12810489"},"language":"en","primary_location":{"id":"doi:10.1001/archneur.60.6.843","doi":"https://doi.org/10.1001/archneur.60.6.843","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archneur.60.6.843","pdf_url":null,"source":{"id":"https://openalex.org/S4210230857","display_name":"Archives of Neurology","issn_l":"0003-9942","issn":["0003-9942","1538-3687"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005259934"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071364728","display_name":"Martin Rhys Farlow","orcid":"https://orcid.org/0000-0001-7897-5471","observed_orcids":["https://orcid.org/0000-0001-7897-5471"]},"institutions":[{"id":"https://openalex.org/I255400825","display_name":"Indiana University Hospital","ror":"https://ror.org/05rbkcx47","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1283055418","https://openalex.org/I255400825","https://openalex.org/I4388446366","https://openalex.org/I592451"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]},{"id":"https://openalex.org/I55769427","display_name":"Indiana University \u2013 Purdue University Indianapolis","ror":"https://ror.org/05gxnyn08","country_code":"US","type":"education","lineage":["https://openalex.org/I55769427","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin Farlow","raw_affiliation_strings":["Department of Neurology, Indiana University School of Medicine, Indianapolis 46202, USA. mfarlow@iupui.edu","Department of Neurology, Indiana University School of Medicine, Indianapolis 46202, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Indiana University School of Medicine, Indianapolis 46202, USA. mfarlow@iupui.edu","institution_ids":["https://openalex.org/I255400825","https://openalex.org/I4394709130","https://openalex.org/I55769427"]},{"raw_affiliation_string":"Department of Neurology, Indiana University School of Medicine, Indianapolis 46202, USA","institution_ids":["https://openalex.org/I4394709130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050834331","display_name":"Steven G. Potkin","orcid":"https://orcid.org/0000-0003-1028-1013","observed_orcids":["https://orcid.org/0000-0003-1028-1013"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steven Potkin","raw_affiliation_strings":["University of California, at Irvine#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, at Irvine#TAB#","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033726367","display_name":"Barbara Koumaras","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Barbara Koumaras","raw_affiliation_strings":["#N##TAB##TAB##TAB##TAB# Novartis#N##TAB##TAB##TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"#N##TAB##TAB##TAB##TAB# Novartis#N##TAB##TAB##TAB#","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108369247","display_name":"Jeffrey Veach","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey Veach","raw_affiliation_strings":["#N##TAB##TAB##TAB##TAB# Novartis#N##TAB##TAB##TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"#N##TAB##TAB##TAB##TAB# Novartis#N##TAB##TAB##TAB#","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067610146","display_name":"Dario F. Mirski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dario Mirski","raw_affiliation_strings":["#N##TAB##TAB##TAB##TAB# Novartis#N##TAB##TAB##TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"#N##TAB##TAB##TAB##TAB# Novartis#N##TAB##TAB##TAB#","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.8144,"has_fulltext":false,"cited_by_count":76,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96603821,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"60","issue":"6","first_page":"843","last_page":"843"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.4668000042438507,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.4668000042438507,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.44699999690055847,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.08259999752044678,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9139999747276306},{"id":"https://openalex.org/keywords/rivastigmine","display_name":"rivastigmine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.972000002861023},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.7329999804496765},{"id":"https://openalex.org/keywords/washout-period","display_name":"washout period","score":0.7799999713897705},{"id":"https://openalex.org/keywords/cognitive-decline","display_name":"cognitive decline","score":0.8859999775886536},{"id":"https://openalex.org/keywords/placebo-effect","display_name":"placebo effect","score":0.32499998807907104},{"id":"https://openalex.org/keywords/adas-cog","display_name":"ADAS-Cog","score":0.7049999833106995},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.3160000145435333},{"id":"https://openalex.org/keywords/mini-mental-state-examination","display_name":"Mini-Mental State Examination","score":0.6159999966621399},{"id":"https://openalex.org/keywords/caregiver-burden","display_name":"caregiver burden","score":0.37299999594688416}],"concepts":[{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.9276926517486572},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7885887622833252},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7159222960472107},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.548781156539917},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5343201756477356},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.4775051474571228},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46671172976493835},{"id":"https://openalex.org/C2984863031","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Cognitive decline","level":4,"score":0.4517084062099457},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.41101691126823425},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2751331627368927},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068836","descriptor_name":"Rivastigmine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009483","descriptor_name":"Neuropsychological Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010352","descriptor_name":"Patient Dropouts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D048448","descriptor_name":"Phenylcarbamates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1001/archneur.60.6.843","doi":"https://doi.org/10.1001/archneur.60.6.843","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archneur.60.6.843","pdf_url":null,"source":{"id":"https://openalex.org/S4210230857","display_name":"Archives of Neurology","issn_l":"0003-9942","issn":["0003-9942","1538-3687"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Neurology","raw_type":"journal-article"},{"id":"pmid:12810489","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12810489","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of neurology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W163864813","https://openalex.org/W961590786","https://openalex.org/W1953027527","https://openalex.org/W1968104857","https://openalex.org/W1977307550","https://openalex.org/W1985528178","https://openalex.org/W1990543766","https://openalex.org/W2007476293","https://openalex.org/W2008559862","https://openalex.org/W2016958718","https://openalex.org/W2019720355","https://openalex.org/W2055727638","https://openalex.org/W2057679568","https://openalex.org/W2060189255","https://openalex.org/W2064097612","https://openalex.org/W2064996887","https://openalex.org/W2076676029","https://openalex.org/W2082111607","https://openalex.org/W2084399566","https://openalex.org/W2100271408","https://openalex.org/W2111912498","https://openalex.org/W2117134611","https://openalex.org/W2120148445","https://openalex.org/W2122692162","https://openalex.org/W2126364822","https://openalex.org/W2156220037","https://openalex.org/W2169741346","https://openalex.org/W2254141218","https://openalex.org/W2402684904","https://openalex.org/W2418663713","https://openalex.org/W2972597017","https://openalex.org/W3216169949","https://openalex.org/W4233035841","https://openalex.org/W4248650858"],"related_works":["https://openalex.org/W4234825459","https://openalex.org/W3213421629","https://openalex.org/W2150409192","https://openalex.org/W2080291833","https://openalex.org/W2001950185","https://openalex.org/W2023649754","https://openalex.org/W2093175987","https://openalex.org/W2037468903","https://openalex.org/W2195733756","https://openalex.org/W2022722753"],"abstract_inverted_index":{"BACKGROUND:":[0],"Treatment":[1],"with":[2,9,16,28,55,107,116,153,247,281,361,406,446,463],"cholinesterase":[3,30],"inhibitors":[4],"improves":[5],"cognition":[6,87,182,454],"in":[7,49,86,94,127,223,251,273,342,353,387,399,413,442,459],"patients":[8,95,115,222,386,438,460],"Alzheimer":[10],"disease":[11,469],"(AD).":[12],"In":[13,216,256,301],"studies":[14,134,206,209,427],"designed":[15,54],"a":[17,29,56,144,260,337,394],"washout":[18,58],"period":[19,59],"at":[20,60,291,371,392,402],"the":[21,24,34,61,64,69,76,84,166,186,197,204,217,224,233,252,266,274,282,302,305,318,329,348,354,362,388,407,415,425],"end":[22,62],"of":[23,37,63,71,101,129,309,385,435,453,457],"study,":[25,142],"after":[26,455],"treatment":[27,106,312,458],"inhibitor":[31],"is":[32],"discontinued,":[33],"cognitive":[35,343,443],"benefits":[36],"therapy":[38,152],"are":[39,214],"no":[40],"longer":[41],"apparent":[42],"following":[43],"washout.":[44],"The":[45,194,332,449],"rivastigmine":[46,151,283,319,363,408,464],"trials":[47,100],"discussed":[48],"this":[50],"article":[51],"were":[52,125,169,183],"not":[53,231],"posttreatment":[57],"study.":[65],"Therefore,":[66],"to":[67,164,171,226,285,321,365,410],"evaluate":[68,83],"effect":[70,467],"discontinuing":[72],"treatment,":[73],"we":[74],"analyzed":[75],"retrieved":[77],"dropout":[78],"(RDO)":[79],"population.":[80],"OBJECTIVE:":[81],"To":[82],"change":[85,269,351],"(at":[88],"week":[89,176,292,372,403],"26":[90,177,293,373,404],"vs":[91,297,377],"baseline)":[92],"observed":[93,272],"from":[96],"3":[97,205],"large":[98],"clinical":[99],"AD":[102,117],"who":[103,156],"prematurely":[104],"discontinued":[105,157],"placebo":[108,254,275,330,355,389],"or":[109],"rivastigmine.":[110],"DESIGN":[111],"AND":[112],"METHODS:":[113],"Eligible":[114],"(Mini-Mental":[118],"State":[119],"Examination":[120],"[MMSE]":[121],"score,":[122,295,375],"10-26,":[123],"inclusive)":[124],"enrolled":[126],"1":[128],"three":[130],"26-week,":[131],"double-blind,":[132],"placebo-controlled":[133],"(Novartis":[135,208],"US":[136,140,199,218,417],"Pivotal":[137,146,200,418],"[dose-range]":[138,147],"Trial,":[139],"fixed-dose":[141],"and":[143,202,212,324,396,424],"Global":[145],"Trial)":[148],"that":[149],"compared":[150,246,280,360,405,445],"placebo.":[154],"Patients":[155],"study":[158],"participation":[159],"(for":[160],"any":[161],"reason)":[162],"(considered":[163],"be":[165,236],"RDO":[167,221,253,258,333],"population)":[168],"encouraged":[170],"return":[172],"for":[173,196,203,240,317,328],"their":[174],"scheduled":[175],"efficacy":[178],"evaluations.":[179],"Effects":[180],"on":[181,265,468],"assessed":[184],"using":[185],"Alzheimer's":[187],"Disease":[188],"Assessment":[189],"Scale-Cognitive":[190],"subscale":[191],"(ADAS-Cog).":[192],"RESULTS:":[193],"results":[195],"Novartis":[198,416],"Trials":[201,419],"combined":[207],"B352,":[210],"B351,":[211],"B303)":[213],"reported.":[215],"pivotal":[219],"trial,":[220],"6-":[225,284,320,364,409],"12-mg/d":[227,286,322,366,411],"group":[228,276,287,323,356,367,390,412],"had":[229],"been":[230],"receiving":[232],"drug":[234],"(to":[235],"called":[237],"\"off":[238],"drug\")":[239],"102":[241],"(57.7)":[242],"days":[243,250,310,316,327],"(mean":[244],"[SD])":[245],"68":[248],"(51.7)":[249],"group.":[255,331],"these":[257],"analyses,":[259],"statistically":[261,338],"significantly":[262,339,382],"greater":[263,340,383],"worsening":[264,398,452],"ADAS-Cog":[267,349,400],"mean":[268,306,350],"score":[270,352],"was":[271,313],"(n":[277,288,357,368],"=":[278,289,358,369],"17)":[279],"33)":[290],"(MMSE":[294,374],"-8.2":[296],"-3.0;":[298],"P":[299,379,422,430],"=.009).":[300],"pooled":[303,426],"studies,":[304],"(SD)":[307],"number":[308],"off":[311],"95":[314],"(52.0)":[315],"66":[325],"(52.7)":[326],"analysis":[334],"also":[335],"showed":[336],"decline":[341],"function":[344,444],"as":[345],"measured":[346],"by":[347],"38)":[359],"88)":[370],"-5.69":[376],"-2.5;":[378],"=.004).":[380],"A":[381],"proportion":[384],"exhibited":[391,439],"least":[393],"4-point":[395],"7-point":[397],"scores":[401],"both":[414],"(P":[420,428],"=.007,":[421],"=.009)":[423],"=.002,":[429],"=.017).":[431],"CONCLUSIONS:":[432],"After":[433],"discontinuation":[434],"therapy,":[436],"rivastigmine-treated":[437],"less":[440,450],"deterioration":[441],"placebo-treated":[447],"patients.":[448],"severe":[451],"withdrawal":[456],"previously":[461],"treated":[462],"suggests":[465],"an":[466],"progression.":[470]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005259934","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
